Press Releases

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Debiopharm Announces Launch of the Phase 1/2 GaLuCi Study for its CA IX-Targeted Radiopharmaceutical Program

Iktos announces closing of € 15.5M series A round co-led by M Ventures and Debiopharm

Debiopharm extends their DNA damage repair footprint with new oncology pipeline entry

Challenge pour la Qualité de vie du patient 2023 : l’appel à projets est ouvert !

Debiopharm Applies Extended-Release Formulation Expertise To Reduce Treatment Frequency Burden For Acromegaly & GEP-NET Patients

Le 7e Challenge Qualité de vie du patient récompense le dispositif de massage MRM destiné aux personnes en fauteuil roulant,…

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial…

Debiopharm reinforces the bond between Swiss and Japanese cancer research with the 2022 JCA-Mauvernay Award Ceremony